Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jean-Michel Azorin, Nicolas Simon, Marc Adida & Raoul Belzeaux. (2016) Pharmacological treatment of schizophrenia with comorbid substance use disorder. Expert Opinion on Pharmacotherapy 17:2, pages 231-253.
Read now
Read now
Marta Torrens, Paola C. Rossi, Roser Martinez-Riera, Diana Martinez-Sanvisens & Antoni Bulbena. (2012) Psychiatric Co-Morbidity and Substance Use Disorders: Treatment in Parallel Systems or in One Integrated System?. Substance Use & Misuse 47:8-9, pages 1005-1014.
Read now
Read now
Michael Soyka & Susanne Rösner. (2010) Emerging drugs to treat alcoholism. Expert Opinion on Emerging Drugs 15:4, pages 695-711.
Read now
Read now
Jan Volavka & Leslie Citrome. (2009) Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making. Expert Opinion on Pharmacotherapy 10:12, pages 1917-1928.
Read now
Read now
Articles from other publishers (14)
Renata Alisauskiene, Erik Johnsen, Rolf Gjestad, Rune A. Kroken, Eirik Kjelby, Igne Sinkeviciute, Farivar Fathian, Inge Joa, Solveig Klæbo Reitan, Maria Rettenbacher & Else-Marie Løberg. (2023) Does drug use affect the efficacy of amisulpride, aripiprazole and olanzapine in patients with schizophrenia spectrum disorders? Results from a pragmatic, randomised study. General Hospital Psychiatry 83, pages 185-193.
Crossref
Crossref
Thomas RE Barnes, Richard Drake, Carol Paton, Stephen J Cooper, Bill Deakin, I Nicol Ferrier, Catherine J Gregory, Peter M Haddad, Oliver D Howes, Ian Jones, Eileen M Joyce, Shôn Lewis, Anne Lingford-Hughes, James H MacCabe, David Cunningham Owens, Maxine X Patel, Julia MA Sinclair, James M Stone, Peter S Talbot, Rachel Upthegrove, Angelika Wieck & Alison R Yung. (2019) Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 34:1, pages 3-78.
Crossref
Crossref
Wolfgang Gaebel, Alkomiet Hasan & Peter Falkai. 2019. S3-Leitlinie Schizophrenie. S3-Leitlinie Schizophrenie
181
254
.
Henk S Temmingh, Taryn Williams, Nandi Siegfried & Dan J Stein. (2018) Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. Cochrane Database of Systematic Reviews 2018:2.
Crossref
Crossref
David Crockford & Donald Addington. (2017) Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders. The Canadian Journal of Psychiatry 62:9, pages 624-634.
Crossref
Crossref
Peter Falkai, Rebecca Schennach, Tania Lincoln, Annette Schaub & Alkomiet Hasan. 2017. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1583
1674
.
Alkomiet Hasan & Peter Falkai. 2016. Praxishandbuch Schizophrenie. Praxishandbuch Schizophrenie
77
105
.
Peter Falkai, Rebecca Schennach, Tania Lincoln, Annette Schaub & Alkomiet Hasan. 2016. Psychiatrie, Psychosomatik, Psychotherapie. Psychiatrie, Psychosomatik, Psychotherapie
1
92
.
A. Millier, U. Schmidt, M.C. Angermeyer, D. Chauhan, V. Murthy, M. Toumi & N. Cadi-Soussi. (2014) Humanistic burden in schizophrenia: A literature review. Journal of Psychiatric Research 54, pages 85-93.
Crossref
Crossref
AR Lingford-Hughes, S Welch, L Peters & DJ Nutt. (2012) BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology 26:7, pages 899-952.
Crossref
Crossref
A George Awad. (2011) Is it time to consider comorbid substance abuse as a new indication for antipsychotic drug development?. Journal of Psychopharmacology 26:7, pages 953-957.
Crossref
Crossref
A. Bechdolf, B. Pohlmann, J. Güttgemanns, C. Geyer, K. Lindner, C. Ferber & E. Gouzoulis-Mayfrank. (2011) Motivationsbehandlung für Patienten mit der Doppeldiagnose Psychose und SuchtState-dependent motivational interviewing for people with schizophrenia and substance use. Der Nervenarzt 83:7, pages 888-896.
Crossref
Crossref
Thomas M. Kelly, Dennis C. Daley & Antoine B. Douaihy. (2012) Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors 37:1, pages 11-24.
Crossref
Crossref
Carlos Roncero, Carmen Barral, Lara Grau-Lopez, Diana Bachiller, Néstor Szerman, Miguel Casas,Pedro Ruiz. (2011) Protocols of Dual Diagnosis Intervention in Schizophrenia. Addictive Disorders & Their Treatment 10:3, pages 131-154.
Crossref
Crossref